We investigated the role of some gp120 peptides on the apoptosis induc
tion in malignant T cell lines. We took advantage of recent findings r
eporting that three major regions of gp120 are important for CD4 bindi
ng. They consist of residues 256-262 in the C2 domain, residues 368-38
9 in the C3 domain, and residues 421-457 in C4 domain. We used a pepti
de from C2 domain (aa 250-263) the homologous major histocompatibility
complex (MHC) class II peptide (aa 135-155) and three peptides from d
omain C4 (aa 464-434; 419-430; 428-445), We selected for this study th
e following human cell lines: CEM and Jurkat, two lymphoblastoid CD4-p
ositive T cell line and U937, a myelomonocytic CD4 positive cell line.
We demonstrated that the CD4-positive T cell lines, in the presence o
f gp120 250-263 peptide and DR 135-155 peptide, can be induced to acce
lerate apoptosis, while no effect in apoptosis induction was observed
in the presence of 414-424 gp120 peptide, Interestingly, we have shown
by fluorescence study, that the small sequence 414-419 must be respon
sible for the inhibition of binding of gp120 to the CD4 molecule, Inde
ed while 414-424 gp120 peptide is very efficient in CD4-gp120 binding
inhibition, no effect is observed in the presence of either 419-430 or
428-445 peptide.